GB2437681A - Methods for identifying compounds capable of modulating CFTR/C2 interaction and/or CFTR phosphorylation by CK2 - Google Patents

Methods for identifying compounds capable of modulating CFTR/C2 interaction and/or CFTR phosphorylation by CK2

Info

Publication number
GB2437681A
GB2437681A GB0715741A GB0715741A GB2437681A GB 2437681 A GB2437681 A GB 2437681A GB 0715741 A GB0715741 A GB 0715741A GB 0715741 A GB0715741 A GB 0715741A GB 2437681 A GB2437681 A GB 2437681A
Authority
GB
United Kingdom
Prior art keywords
cftr
interaction
phosphorylation
methods
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0715741A
Other versions
GB2437681B (en
GB0715741D0 (en
Inventor
Anil Mehta
Russell Crawford
Kathryn Treharne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0500607A external-priority patent/GB0500607D0/en
Priority claimed from GB0507463A external-priority patent/GB0507463D0/en
Application filed by University of Dundee filed Critical University of Dundee
Publication of GB0715741D0 publication Critical patent/GB0715741D0/en
Publication of GB2437681A publication Critical patent/GB2437681A/en
Application granted granted Critical
Publication of GB2437681B publication Critical patent/GB2437681B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/382—Cystic fibrosis

Abstract

A method of identifying a compound capable of modulating CFTR/CK2 interaction and/or CFTR phosphorylation by CK2 comprising exposing CFTR and/or CK2 to a test compound and assessing the effect of the test compound on CFTR/CK2 interaction and/or CFTR phosphorylation by CK2. A method of screening for compounds of use in preventing or treating a secretory state or disorder and/or a cancer and/or cystic fibrosis wherein CFTR and/or CK2 is exposed to a test compound and the effect of the test compound on CFTR/CK2 interaction and/or CFTR phosphorylation by CK2 is assessed.
GB0715741A 2005-01-13 2007-08-13 Methods of identifying modulators of CFTR/CK2 interaction Expired - Fee Related GB2437681B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0500607A GB0500607D0 (en) 2005-01-13 2005-01-13 Methods
GB0507463A GB0507463D0 (en) 2005-04-13 2005-04-13 Methods
PCT/GB2006/000122 WO2006075172A2 (en) 2005-01-13 2006-01-13 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2

Publications (3)

Publication Number Publication Date
GB0715741D0 GB0715741D0 (en) 2007-09-19
GB2437681A true GB2437681A (en) 2007-10-31
GB2437681B GB2437681B (en) 2009-10-21

Family

ID=36371733

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0715741A Expired - Fee Related GB2437681B (en) 2005-01-13 2007-08-13 Methods of identifying modulators of CFTR/CK2 interaction

Country Status (2)

Country Link
GB (1) GB2437681B (en)
WO (1) WO2006075172A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
US9447458B2 (en) * 2011-11-16 2016-09-20 Canon U.S. Life Sciences, Inc. Detection of neighboring variants
WO2023167516A1 (en) * 2022-03-03 2023-09-07 숙명여자대학교 산학협력단 Novel 2-(phenylamino)pyridine-based tead inhibitor and pharmaceutical composition comprising same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005273A1 (en) * 1990-09-18 1992-04-02 The Regents Of The University Of Michigan Gene therapy for cystic fibrosis
US20010041685A1 (en) * 2000-01-31 2001-11-15 Yuhong Zhou Mucin synthesis inhibitors
US6620795B1 (en) * 1991-12-17 2003-09-16 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
WO2003087389A2 (en) * 2002-04-08 2003-10-23 Genesegues, Inc. Biologic modulations with nanoparticles
US20040121968A1 (en) * 2002-12-23 2004-06-24 Alexander Ljubimov Antiangiogenesis by inhibiting protein kinase CK2 activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005273A1 (en) * 1990-09-18 1992-04-02 The Regents Of The University Of Michigan Gene therapy for cystic fibrosis
US6620795B1 (en) * 1991-12-17 2003-09-16 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US20010041685A1 (en) * 2000-01-31 2001-11-15 Yuhong Zhou Mucin synthesis inhibitors
WO2003087389A2 (en) * 2002-04-08 2003-10-23 Genesegues, Inc. Biologic modulations with nanoparticles
US20040121968A1 (en) * 2002-12-23 2004-06-24 Alexander Ljubimov Antiangiogenesis by inhibiting protein kinase CK2 activity

Also Published As

Publication number Publication date
WO2006075172A2 (en) 2006-07-20
GB2437681B (en) 2009-10-21
WO2006075172A3 (en) 2006-09-14
GB0715741D0 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
TW200716624A (en) Compounds for modulating TRPV3 function
WO2005028624A3 (en) Molecular scaffolds for kinase ligand development
GB0602197D0 (en) Apparatus and methods for seismic streamer positioning
DE602006017558D1 (en) DEVICE AND METHOD FOR CARRYING OUT POLARIZATION-BASED QUADRATURE DEMODULATION IN OPTICAL COHERENCE TOMOGRAPHY
TW200700902A (en) Photosensitive composition containing organic fine particle
ATE410719T1 (en) PROJECTION DEVICE AND METHOD FOR HOLOGRAPHIC RECONSTRUCTION OF SCENES
ATA14022004A (en) DEVICE FOR DISPERSING DISPERSED PARTICLES
ATE544094T1 (en) COMPOUND FOR USE IN A PHOTOSENSITIVE COMPOSITION
FI20050445A0 (en) Method and apparatus for removing interference from electromagnetic multichannel measurement
GT200600407A (en) ACTIVE PPAR COMPOUNDS
ATE428818T1 (en) METHOD FOR BLEACHING SUBSTRATES
FI20055596A (en) Data sheet and method for producing the data sheet
IL177666A0 (en) Methods, apparatus and computer programs for enabling web-applications to access enterprise managed data
DE502006005765D1 (en) Detection and device for the detection of recording media
PL376770A1 (en) Asparaginyl hydroxylases and modulators thereof
DE502006003575D1 (en) HOUSING FOR SHIELDING OF ELECTROMAGNETIC INTERFERENCE
ZA200806515B (en) Method for determining the identity or non-identity and concentration of a chemical compound in a medium
GB2437681A (en) Methods for identifying compounds capable of modulating CFTR/C2 interaction and/or CFTR phosphorylation by CK2
DE602006016542D1 (en) Developer role and development process for it
NO20051327D0 (en) Method and apparatus for installing a bottom gasket
ATE467641T1 (en) LIBRARY OF TOXIN MUTANTS AND THEIR USE
WO2007067809A3 (en) Methods of identifying agents that modulate mitochondrial function
TW200730801A (en) Apparatus and method for improving detected resolution and/or intensity of a sampled image
DE502005002994D1 (en) Method and apparatus for determining the concentrations of at least two ligands
EP1952237A4 (en) Apparatus and method for analysis of optical storage media

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120113